Sylvie Hermouet, Mathias Vilaine. The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?. haematol [Internet]. 2011Nov.4 [cited 2024Apr.27];96(11):1575-9. Available from: https://haematologica.org/article/view/6114